Longevity
From lab to factory: Klotho reaches a new milestone
Avaí Bio completes a manufacturing step that could move one of longevity’s most-watched proteins closer to the clinic. The hardest part of longevity may be figuring out how to manufacture it. That idea feels especially timely after Avaí Bio announced it has completed a Good Manufacturing Practice (GMP) Master Cell Bank for its alpha-Klotho therapy […] The post From lab to factory: Klotho reaches a new milestone appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →